|
1) de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000; 52: 415-72
|
|
|
|
2) Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009; 119: 524-30
|
|
|
|
|
3) Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109: 1417-27
|
|
|
|
|
|
4) Krop M, de Bruyn JH, Derkx FH, et al. Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding？ Front Biosci. 2008; 13: 3931-9
|
|
|
|
|
|
5) Huang Y, Noble NA, Zhang J, et al. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007; 72: 45-52
|
|
|
|
|
|
6) Saris JJ, 't Hoen PA, Garrelds IM, et al. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II. Hypertension. 2006; 48: 564-71
|
|
|
|
|
|
7) Schefe JH, Menk M, Reinemund J, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006; 99: 1355-66
|
|
|
|
|
|
8) Ichihara A, Hayashi M, Kaneshiro Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle" region for nonproteolytic activation of prorenin. J Clin Invest. 2004; 114: 1128-35
|
|
|
|
|
|
9) Feldt S, Batenburg WW, Mazak I, et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008; 51: 682-8
|
|
|
|
|
|
10) Yoshikawa A, Aizaki Y, Maruyama K, et al. A Novel Mechanism: Activation of (pro)renin receptor requires its ectodomain shedding. American Heart Association Scientific Meeting. 2007
|
|
|
|
|
|
11) Cousin C, Bracquart D, Contrepas A, et al. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension. 2009; 53: 1077-82
|
|
|
|
|
|
12) Nabi AH, Kageshima A, Uddin MN, et al. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006; 18: 483-8
|
|
|
|
|
|
13) Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006; 69: 105-13
|
|
|
|
|
|
14) Parving HH, Persson F, Lewis JB, et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008; 358: 2433-46
|
|
|
|
|
|
15) Ichihara A, Kaneshiro Y, Takemitsu T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006; 47: 894-900
|
|
|
|
|
|
16) Batenburg WW, Krop M, Garrelds IM, et al. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens. 2007; 25: 2441-53
|
|
|
|
|
|
17) Senbonmatsu T, Saito T, Landon EJ, et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 2003; 22: 6471-82
|
|
|
|
|
|
18) Ramser J, Abidi FE, Burckle CA, et al. A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet. 2005; 14: 1019-27
|
|
|
|
|
|
19) Yoshikawa A, Aizaki Y, Iida S, et al. Shedding of (pro)renin receptor is essential for intracellular signaling. American Heart Association Scientific Meeting. 2008
|
|
|
|
|
|
20) Thyberg J, Moskalewski S. Role of microtubules in the organization of the Golgi complex. Exp Cell Res. 1999; 246: 263-79
|
|
|
|
|
|
21) Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007; 98: 621-8
|
|
|
|
|
22) Yokozeki T, Wakatsuki S, Hatsuzawa K, et al. Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. Genes Cells. 2007; 12: 329-43
|
|
|
|
|
|
23) Melenhorst WB, van den Heuvel MC, Timmer A, et al. ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration. Kidney Int. 2006; 70: 1269-78
|
|
|
|
|